Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Peel Hunt
$81.00
Provider: Peel Hunt
$23.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Toumaz Ltd's SensiumVitals Receives CE Marking


Tuesday, 15 Oct 2013 02:00am EDT 

Toumaz Ltd announced that SensiumVitals, its ultra-low power system for wireless monitoring of patient vital signs, has received CE marking under the EU Medical Devices Directive. The CE Mark allows the system to be sold throughout the European Union, and follows the product's US FDA 510k clearance, received in July 2011. The Group has also secured the first UK pilot deployment of SensiumVitals with Spire Healthcare ('Spire'), a UK provider of private healthcare. The pilot will start in a Spire Healthcare hospital in early 2014. 

Company Quote

4.625
0.0 +0.00%
17 Apr 2014